Accel Wealth Management - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Accel Wealth Management ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$1,135
+25.3%
3180.0%0.00%
Q4 2022$906
-9.4%
3180.0%0.00%
-100.0%
Q3 2022$1,000
-90.9%
318
-92.6%
0.00%
-83.3%
Q2 2022$11,0004,3000.01%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 829,042$9,376,0005.61%
P.A.W. CAPITAL CORP 120,000$1,357,0001.24%
Nantahala Capital Management 2,539,700$28,724,0001.01%
Slate Path Capital LP 1,483,619$16,780,0000.88%
SANDERS MORRIS HARRIS LLC 359,113$4,416,0000.76%
APOGEM CAPITAL LLC 62,295$705,0000.46%
Robertson Stephens Wealth Management, LLC 478,500$5,411,0000.46%
Bleichroeder LP 200,000$2,262,0000.35%
ADVISORY RESEARCH INC 257,225$2,909,0000.23%
Granite Point Capital Management, L.P. 110,000$1,244,0000.21%
View complete list of CUE BIOPHARMA INC shareholders